Redhill Biopharma (NASDAQ:RDHL) reported its Q1 earnings results on Thursday, June 23, 2022 at 07:00 AM.

Here's what investors need to know about the announcement.

Earnings

Redhill Biopharma reported an EPS of $0.03.

Revenue was down $2.34 million from the same period last year.

Past Earnings Performance

Last quarter the company beat on EPS by $0.28 which was followed by a 12.72% increase in the share price the next day.

Here's a look at Redhill Biopharma's past performance:

To track all earnings releases for Redhill Biopharma visit their earnings calendar here.

This article was generated by Benzinga's automated content engine and reviewed by an editor.